Physician
Abu-Nijmeh, Nadia
Abu-Nijmeh, Nadia was paid $2.16M by Medicaid between Jan 2018 and Dec 2024, across 65 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 22% of everything it billed.
33Billing provider infoABU-NIJMEH, NADIA
AURORA, IL 60504
AURORA, IL 60504
33aNPI1972554533assigned 05/16/2006
33bProvider typePediatrics Physician
28Total paid$2.16M
24GClaims57,062
24DCodes billed65
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Illinois
Rank by total paid#43 of 1,805
Median peer was paid$55K
This provider vs. median39×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,155 | $501K | |
| 2019 | 15,585 | $535K | |
| 2020 | 5,524 | $199K | |
| 2021 | 5,631 | $215K | |
| 2022 | 5,070 | $222K | |
| 2023 | 5,307 | $234K | |
| 2024incomplete | 5,790 | $253K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 10,130 | 7,923 | $469K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 3,740 | 3,017 | $276K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 12% | 3,356 | 2,677 | $256K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 10% | 2,593 | 2,296 | $216K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 9.7% | 2,767 | 2,410 | $209K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 9.4% | 2,980 | 2,377 | $204K |
| 96127 | 3.1% | 4,329 | 3,588 | $66K | |
| 90686 | 2.5% | 5,118 | 4,315 | $55K | |
| 90651 | 2.0% | 1,246 | 1,012 | $43K | |
| D1206 | Topical application of fluoride varnish | 1.5% | 1,253 | 930 | $33K |
| 90670 | 1.3% | 1,751 | 1,445 | $27K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.3% | 1,627 | 1,362 | $27K |
53 more codes
| 90620 | 1.1% | 781 | $24K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.0% | 492 | $22K |
| 90677 | 1.0% | 399 | $22K | |
| 90734 | <1% | 721 | $18K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,126 | $18K |
| 90698 | <1% | 1,404 | $17K | |
| 92558 | <1% | 1,303 | $15K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,158 | $14K |
| 90633 | <1% | 1,103 | $13K | |
| 90680 | <1% | 815 | $10K | |
| 95930 | <1% | 151 | $7K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 138 | $7K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 77 | $7K |
| 90744 | <1% | 533 | $7K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 93 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 245 | $6K |
| 90648 | <1% | 708 | $5K | |
| 90723 | <1% | 523 | $5K | |
| 90715 | <1% | 379 | $5K | |
| 90681 | <1% | 261 | $5K | |
| 90661 | <1% | 286 | $5K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 187 | $5K |
| 90619 | <1% | 239 | $4K | |
| 99383 | <1% | 35 | $3K | |
| 0071A | <1% | 74 | $3K | |
| 90710 | <1% | 121 | $3K | |
| 90656 | <1% | 178 | $3K | |
| 0124A | <1% | 65 | $3K | |
| 0001A | <1% | 59 | $2K | |
| 99000 | <1% | 112 | $2K | |
| 99173 | <1% | 268 | $2K | |
| 99384 | <1% | 15 | $2K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 13 | $1K |
| 94760 | <1% | 869 | $1K | |
| 90716 | <1% | 64 | $891.28 | |
| 90685 | <1% | 128 | $872.00 | |
| 0072A | <1% | 20 | $842.80 | |
| 90707 | <1% | 61 | $667.68 | |
| 90696 | <1% | 43 | $642.73 | |
| 83655 | <1% | 44 | $521.84 | |
| 0054A | <1% | 12 | $501.60 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 20 | $275.50 |
| 90700 | <1% | 25 | $250.00 | |
| 90381 | <1% | 14 | $236.94 | |
| 81002 | <1% | 81 | $210.60 | |
| 85018 | <1% | 53 | $122.96 | |
| A4556 | Electrodes, (e.g., apnea monitor), per pair | <1% | 22 | $47.20 |
| A6411 | Eye pad, non-sterile, each | <1% | 200 | $36.64 |
| A4558 | Conductive gel or paste, for use with electrical device (e.g., tens, nmes), per oz | <1% | 22 | $15.65 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 99 | $0.00 |
| 99177 | 0% | 37 | $0.00 | |
| 99188 | 0% | 20 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 276 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.